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INTRODUCTION 
This thesis deals with the studies carried for the simultaneous 
estimation of calcium pantothenate and biotin in tablet dosage form by RP-
HPLC Method. 
Modern medicines for human consumption are required to meet exact 
standards which relate to their quality, safety and efficacy. The evaluation of 
safety and their maintenance in practice is dependent upon the existence of 
adequate methods for quality control of products. The purity of standard is a 
must therefore, it can strictly define in such a way as to ensure that 
successive batches are consistent in composition, irrespective of whether 
they came from the same or different manufactures. Here lies the work of the 
analytical chemist. 
Definition:  
           Pharmaceutical analysis is branch of pharmaceutical chemistry, which 
is define as a process or a sequence of processes to identify and quantify a 
substance or drugs the components of a pharmaceutical solution or mixture or 
the determination of the structural of chemical compounds used in the 
formulation of pharmaceutical products1. 
Pharmaceutical Analysis:  
           Modern methods of pharmaceutical analysis are extremely sensitive, 
providing precise and detailed information from small samples of materials. In 
general they are readily amenable to automation and also this method is very 
rapid, due to this reasons they are now in widespread use in the product 
development in the control of manufacturing formulations, as a check on 
stability during storage and in monitoring the use of drugs and medicine2, 3. 
Role of analytical chemistry in pharmaceutical analysis 4, 5:  
           Analytical chemistry may be defined as the science and art of 
determining the composition of materials in terms of the elements of 
composition contained.  Its prime importance is to gain about the qualitative 
and the quantitative information of the drug substance or chemical species 
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i.e., to find out what a substance is composed of and how much. In relation of 
this context pharmaceutical analysis plays an important role in the quality 
assurance and quality control of drug samples as well as pharmaceutical 
formulations. In this connection it should be emphasized that the pharmacists 
should be aware and capable of developing new methods for the purpose of 
keeping the pharmaceutical industries and quality control laboratories in 
viable position. The best way to characterize the quality of the drug is to 
determine its purity. There are two possible approaches to reach this goal. 
1. Determination of Active Pharmaceutical Ingredient (API). 
2. Determination of its impurities with a highly accurate and precise 
specific method. 
Drugs and pharmaceuticals are chemicals or like substances, which 
are of organic, inorganic or other origin. Whatever may be the origin, we use 
some property of the medicinal agent to measure them qualitatively or 
qualitatively. Pharmaceutical analytical techniques, which are being used, can 
be categorized as follows. 
Analytical Techniques:  
           There are three types analytical techniques are used as follows 6: 
                     1. Spectroscopic analysis. 
                     2. Electrochemical analysis.  
                     3. Chromatographic technique. 
SPECTROSCOPY:  
           Measurement based on light and other forms of electromagnetic 
radiation are widely used to thought analytical chemistry. The interactions of 
radiation and matter are the subject of the science called spectrometry. 
Spectroscopic analytical methods are based on the measurement the amount 
radiation produce or absorbed by molecular or atomic species of interest 7. 
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Spectrophotometric Methods:  
           The light absorption (or) emission characteristic of drugs is measured 
such as UV-Visible, IR, NMR, ESR, fluorescence and mass spectroscopy. 
 
UV-Visible - Changes in electronic energy levels within the 
molecule. 
Infrared - Changes in the vibrational and rotational movements 
of the Molecule. 
Microwave - Electron spin resonance or electron paramagnetic 
resonance induces changes in the magnetic 
properties of unpaired electron. 
Radiofrequency - Nuclear magnetic resonance; induces changes in the 
magnetic properties of certain atomic nuclei, notably 
that of hydrogen and the C13 isotope of carbon 8. 
Quantitative spectrophotometric assay of medical substance by using 
UV-Visible spectroscopy: 
The assay of an absorbing substance may be quickly carried out by 
preparing a solution in a transparent solvent and measuring its absorption at a 
suitable wavelength of maximum absorption where small errors in setting the 
wavelength scale have little effect on the measurement absorbance of 
approximately 0.9, around which the accuracy and precision of measurement 
are optimal. The concentration of the absorbing substance is then calculated 
from the measured absorbance using one of these principal procedures 9. 
1. Use of standard absorptivity value. 
2. Use of calibration graph. 
3. Single or double point standardization. 
4. Assay of substances multicomponent samples. 
5. Assay as a single components sample. 
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6. Assay using absorbance corrected for interference. 
7. Assay of after solvent extraction of the sample. 
8. Simultaneous equations method. 
9. Absorbance ratio method. 
10. Geometric correction method 9. 
CHROMATOGRAPHY: 
Chromatography may be defined as a method of separating mixture of 
components into individual components though equilibrium distribution 
between two phases. Especially, the technique of chromatography is based 
on the difference in the rate at which the components of the mixture move 
thorough a porous medium under the influence of some solvent or gas. The 
chromatographic method of separation, in general, it involves the following 
steps (i.e) adsorption or retention of substance or substance on the stationary 
phase. Separated substance by a continuous flow of mobile phase, the 
method is being called elution.                                              
High Performance Liquid Chromatography (HPLC): 
The technique is based on the same mode of separation as that 
classical column chromatography that is adsorption, partition, ion exchange 
and gel permeation, but it differs from column chromatography in that the 
mobile phase is pumped through the packed column under high pressure. 
High performance liquid chromatography is a very sensitive analytical 
technique most widely used for quantitative and qualitative analysis of 
pharmaceuticals. The principle advantage of HPLC compared to classical 
column chromatography is improved resolution of the separated substance, 
faster separation times and the increased accuracy, precision, and sensitivity. 
High-performance liquid chromatography sometimes referred to as high-
pressure liquid chromatography, which is a chromatographic technique used 
to separate a mixture of compounds in analytical chemistry with the purpose 
of identifying, quantifying and purifying the individual components of the 
mixture 10, 11.  
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Principle involved in HPLC: 
           The principle of separation in normal phase mode and reverse phase 
mode is adsorption. The component which has more affinity towards the 
adsorbent travels slower. The component which has less affinity towards the 
stationary phase travels faster. Since no two components have the same 
affinity towards the stationary phase, the components are separated. 
Instrumentation: 
           Solvents must be degassed to eliminate formation of bubbles. The 
pumps provide a steady high pressure with no pulsating, and can be 
programmed to vary the composition of the solvent during the course of the 
separation. Detectors rely on a change in refractive index, UV-VIS absorption, 
or fluorescence after excitation with a suitable wavelength. The different types 
of HPLC columns are described in a separate document. 
          A column (or other support for TLC, see below) holds the stationary 
phase and the mobile phase carries the sample through it. Sample 
components that partition strongly into the stationary phase spend a greater 
amount of time in the column and are separated from components that stay 
predominantly in the mobile phase and pass through the column faster.                                
 
Figure1: Schematic diagram of an HPLC instrument. 
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Detector: 
      Optical. 
      Equipped with a flow cell. 
      Focus light beam at the center for maximum energy transmission. 
      Cell ensures that the separated bands do not wide11, 12.                         
ELECTROCHEMICAL ANALYSIS: 
In electrochemical analysis one or more electrically related parameters 
e.g.:-voltage, current, or charge are measured and related to the state of the 
system generating or carrying the charge. In addition these methods can be 
divided into those relating as in gram to system equilibrium. The combination 
of electro-analytical methods with chromatography is a powerful tool for both 
qualitative and quantitative work. It is measured based on the electrochemical 
property of drugs and classified as potentiometry, conductometry, 
polarography and amperometry. 
Physical methods: 
            The physical characteristics of drugs are measured such as DSC, 
DTA, TGA and TMA.  
Radio-active methods:  
In this method, radiation intensity from a radioactive substance or an 
induced radioactive substance arising from exposure of the sample to a 
neutron source is measured using scintillation counters. e.g., 
radioimmunoassay 
Titrimetric methods:  
It is based on the reaction between titrant and titrate and the end point 
detected by the addition of a suitable indicator reagent. It is classified in to 
several types based on the reaction which is non aqueous, redox, 
diazotization and complexometric titrations. 
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X-ray methods: 
            In this, x-ray is used to identify certain emission peaks, which are 
characteristics of elements contained in the target. The wavelength of the 
peak can be related to the atomic numbers of the elements producing them. 
Other techniques such as combination of two or more methods where 
separation and identification is possible by using coupled instruments such as 
GC-MS and LC-MS.  
DEFINITION OF VALIDATION: 
           As per USP, validation of an analytical procedure is the process by 
which it is established, by laboratory studies, that the performance 
characteristics of the procedure meet the requirements for the intended 
analytical applications 13. 
 
Validation process: 
      The real goal of the validation process is to challenge the method and 
determine the limits or allowed deriability for the condition needed to the 
method. 
      1. Specificity  
      2. Linearity 
      3. Range   
      4. Accuracy 
      5. Precision 
      6. Detection limit 
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      7. Quantification limit  
      8. Robustness 
      9. System suitability testing 
Methodology: 
The real goal of the validation process is to challenge the method and 
determine the limits or allowed deriability for the condition needed to the 
method. 
Types of analytical procedure to be validated: 
 Identification test. 
           Quantitative test for impurities contents. 
 Limit test for the control of impurities. 
 Quantitative test of the active molecule in samples of drug substance 
or drug product. 
Analytical procedure: 
It refers to the way of performing the analysis. 
1. Specificity: 
 An investigation of specificity should be conducted during the validation 
of identification test, determination of impurities and assay. 
           a. Identification: 
         To ensure the identity of an analyte. 
           b. Purity test: 
        To ensure that all the procedure performed allow an accurate 
statement of the control of impurity of an analyte. 
           c. Assay (content of potency): 
        To provide an exact result which allow an accurate statement on 
the content of the analyte in a sample. 
INTRODUCTION 
Dept. of Pharmaceutical Analysis 
Arulmigu Kalasalingam College of Pharmacy Page 9 
2. Linearity: 
           The linearity of an analytical procedure is of ability (within a given 
range) to obtain test result while are directly proportional to the concentration 
of analyte in the dam pole for establishment of linearity. A minimum of 5 
concentrations is recommended other approaches would justified. 
3. Range: 
The range of analytical procedure is the introduce between the upper 
and lower concentration of an analyte in the sample. The specific range is 
normally derived from linearity studies and depending on the intended 
application procedure. The following minimum specified ranges should be 
considered. 
For assay of drug substance: Normally from so to use of the test 
concentration. 
For content uniformity: - 70-80% of the concentration. 
For dissolution release product 20% other one hour upto 40% after 24 
hour for the validating range would be 0-100% of the label claim. 
4. Accuracy: 
Accuracy on the method was determined by relative and absolute 
recovery experiments.         
           a. Drug substances: 
        Application of an analytical procedure to analyte of known purity of 
reference material. 
                   Comparison of request with those of second well characterized 
procedure, the accuracy of which is stated.  
           b. Drug product: 
        Application of an analytical procedure to analyte of known purity of 
reference the accuracy of which is state. 
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           c. Impurities: 
        Accuracy should be assessed on sample splinked with known 
amount of impurities. Compare there to independent procedure. 
           d. Recommended data: 
       Accuracy should be assessed using a minimum of a determination 
over a minimum of 3 concentration levels covering a specified range. 
5. Precision: 
 Validation of test for assay and quantitative determination of impurities 
includes an included an investigation of precision. 
           a. Repeatability: 
                   A minimum of a determination covering the specified range for 
procedure (or) A minimum of 6 determination at 100% of the test. 
           b. Intermediate precision: 
        The applicant should establish the affects of random events on the 
precision of analytical procedure. 
           c. Reproducibility: 
        Reproducibility is assessed by means of an inter laboratory test 
this should be considered in case of standardization of analytical procedure 
for instance for inclusion, and procedure in I.P. 
Standard deviation, relative standard deviation and confidence interval 
should be reported for each type of precision investigation. 
6. Detection limit: 
     The detection limit of an individual analytical procedure is the lowest 
amount of analyte is a sample which can be detected but not necessary 
quantified as an exact value approaches other than those listed below may be 
acceptable. 
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     Based on visual evaluation. 
     Based on signal to raise. 
     Based on the standard deviation on the response and slope. 
     Based on the standard deviation of the blank. 
     Based on the calibration curve. 
     Recommended data. 
Detection levels and determination method detection limit should be 
presented.  
The detection limit (LOD) may be expressed as: 
                     LOD          =       3.3σ/S 
Where,            = The standard deviation of the response. 
  S = The slope of the calibration curve (of an analyte). 
7. Quantification limit: 
The quantitative limit of an individual analytical procedure is the lowest 
amount of an analyte in the sample which can be quantitative determined with 
suitable precision and accuracy. The quantification limit is a parameter of 
quantitative assay of law levels of compound in sample material and it is used 
particularly for the determination of impurity. 
Quantification Limit (LOQ) may be expressed as: 
                     LOQ          =       10/S 
Where,      = The standard deviation of the response. 
            S = The slope of the calibration curve (of an analyte). 
8. Robustness: 
 The robustness of the method was determined by analyzing the 
standard solution six times followed by a sample in duplicate with varying 
HPLC conditions as described below, 
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Examples of typical variation are: 
     Stability of analytical solution. 
     Extraction time. 
     In case of liquid chromatography examples of typical variation are. 
     Influence of variation of pH in mobile phase. 
     Influence of variation of pH in mobile phase components. 
     Different column. 
     Temperature. 
     Flow rate. 
9. System suitability testing: 
 System suitability testing is an integral part of many analytical 
procedures. The tests are based on the concept that the equipment, 
electronics, analytical operations, and samples to be analyzed constitute an 
integral system that can be evaluated as such. System suitability test 
parameters to be established for a particular procedure depend on the type of 
procedure being validated.  
The parameters that are affected by the changes in chromatographic 
conditions are, 
                Retention (KA) 
                Resolution (Rs) 
                Capacity factor (k’) 
                Selectivity () 
                Column efficiency (N)  and 
                Peak asymmetry factor (As) 
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LITERATURE REVIEW 
Havlikova L et al14., 2006 carried out research about HPLC 
determination of calcium pantothenate and two preservatives in topical cream 
and reported as simultaneous determination of calcium pantothenate and two 
preservatives methylparaben and propylparaben present in topical cream. 
Different analytical columns with various stationary phases were tested. 
During method development, Supelco Discovery C18 column 
(125 mm × 4.0 mm, 5 μm) and Zorbax SB-CN column (150 mm × 4.6 mm, 
5 μm) were tested. Both were not convenient for analytical separation 
because of the co-elution of calcium pantothenate with dead volume, and 
problems with the peak-shape of all components. Good separation was 
achieved using Zorbax TSM (250 mm × 4.6 mm, 5 μm) and Hypersil ODS 
column (250 mm × 4.6 mm, 5 μm), the latter was finally used for the analysis. 
The analysis time was 12 min, at flow rate 0.7 ml min−1. Chromatography was 
performed using binary mobile phase composed of methanol and phosphoric 
acid, pH 2.5, 65:35 (v/v). UV detection was accomplished at 214 nm. The 
method was validated according to ICH guideline recommendations. The 
method is suitable for practical routine analysis of commercially produced 
topical pharmaceutical preparations. 
Thomas J Franks et al15., 2006 developed “A Reverse Phase HPLC 
Assay for the Determination of Calcium Pantothenate Utilizing Column 
Switching” and summarized as a reverse phase HPLC assay utilizing column 
switching has been developed and validated for the determination of calcium 
pantothenate (CP) in several multivitamin tablet formulations. The reverse 
phase system utilizes a DuPont Zorbax C-8 analytical column, an 
automatically switched and back flushed Brownlee RP-18 guard column for 
the elimination of a highly retained excipient peak, 88:12 0.25M phosphate 
buffer: CH3OH mobile phase, and 214 nm detection. Sample preparation and 
the switched column chromatography cycle each require approximately 15 
minutes. A spiked recovery study showed linearity over the 50–150% of 
theory concentration range. Average recovery was 99.7%. Assay precision 
studies yielded sample RSD's ranging from 0.8 to 2.3%. Results obtained by 
this method are comparable to those obtained by the USP method. 
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Huangmin et al16., 2009 carried out research in “Measurement of 
Water-Soluble B Vitamins in Infant Formula by Liquid 
Chromatography/Tandem Mass Spectrometry.” A method has been 
developed for the simultaneous measurement of multiple B vitamins (i.e., B1, 
B2, B3, B5, and B6) in infant formulas by LC-MS/MS. The vitamins were 
extracted with acidic solvent, followed by protein precipitation at a pH range of 
4.5 to 5.5, and filtered. This simplified procedure eliminates many of the 
potential sources of laboratory error and facilitates rapid and efficient analysis. 
As is common in most cases, isotope internal standards were added to 
account for variations in sample preparation, as well as changes in MS 
measurement. In this method, isotope-labeled internal standards of B1, B3, B5, 
and B6 were used. The factors affecting analytical performance were 
investigated and optimized. In addition, the stability of these vitamins in the 
extraction solution was investigated. An acidic condition (5M HCl) was applied 
to successfully stabilize B1, which had shown a decrease in signal when other 
solvents were used. The quantitative extraction and good stability allowed 
isotope standards to be added to the filtered sample solution, instead of to the 
extraction solvent. The addition of the isotope to the small portion of the 
filtered sample solution significantly reduces cost. A comprehensive 
evaluation of the analysis of the standard reference material and good spike 
recovery of the vitamins demonstrates the accuracy of the method. The 
results for commercially available infant formula samples were also compared 
with those obtained using the current microbiological method. 
Karuppiah SP et al17., 2015 worked in “Phytochemical evaluation of 
hydroxy citric acid, catechins and calcium pantothenate present in herbal 
formulation” and concluded as the analytical method for the estimation of 
phytochemical active ingredients present in Garginia combogia extract with 
calcium pantothenate for herbal formulations are evaluate for its assay 
content and dissolution release. This herbal formulation with slim formula 
consists of several active ingredients such as hydroxy citric acid, catechins 
and calcium pantothenate. The HPLC method for the estimation of active 
content an in-vitro dissolution release is developed for the study. 
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Ulrich Holler et al18., 2005, carried  out research in ”Quantification of 
biotin in feed, food, tablets, and premixes using HPLC–MS/MS and 
summarized as two sensitive and specific methods for quantification of biotin 
in feed, food, tablets, and premixes based on HPLC–MS/MS have been 
developed and validated. Depending on sample matrix and biotin content 
different extraction procedures and HPLC conditions were applied. Key steps 
in sample preparation were an alkaline extraction or a hydrolysis with 
sulphuric acid followed by enzymatic digest with papain. For many samples 
with low biotin content the latter combination of extraction steps was shown to 
be necessary for an optimal release of biotin from the matrix. The first time 
synthesis of deuterated biotin for use as internal standard allowed the 
compensation of losses during sample work-up and ion suppression during 
HPLC–MS/MS analysis. The new methods are faster than the commonly used 
microbiological assay using Lactobacillus plantarum. Additionally, they have a 
higher specificity as results for biotin are based on determination of a 
chemically defined compound, and not of a biological activity. Quantification is 
applicable to samples with a biotin content >100 μg/kg. Results obtained with 
the new methods have been compared with those of the microbiological 
assay, and were in good agreement. 
AnthonyE.Ekpe et al19.,1997, developed method for “Liquid 
chromatographic determination of biotin in multivitamin-multimineral tablets” A 
reproducible reverse phase high pressure liquid chromatography (RP-HPLC) 
method for the determination of biotin in multivitamin-multimineral tablets has 
been developed and validated. This method involves reverse phase 
separation of the component monitored by absorbance at 200 nm wavelength. 
The method has excellent precision and accuracy with S.D. 0.83 and 2.9%, 
respectively. The established linearity range was 0.5–2 μg ml−1 (r2>0.9999). 
The recovery of biotin from spiked placebo was >97% over the linear range. 
The extraction procedure is simple and the HPLC conditions separate biotin 
from its degradation products and excipients. The method has been 
successfully used in determining biotin content in 4 brands of commercially 
available multivitamin- multimineral tablets. 
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Chikakoyomota et al20., 2016, carried out research in”Determination of 
biotin following derivatization with 2-nitrophenylhydrazine by high-
performance liquid chromatography with on-line UV detection and 
electrospray-ionization mass spectrometry” Currently, biotin is typically 
determined in Japan using a microbiological method. Such microbiological 
assays are sensitive, but they are not always highly specific and are also 
rather tedious and time-consuming. In the present study, RP-HPLC and LC–
MS methods for the determination of biotin have been developed by 
derivatizing the carboxyl group with 2-nitrophenylhydrazine hydrochloride. 2-
Nitrophenylhydrazine is used for the derivatization of carboxylic acids, and 
these derivatives are known to be applicable to LC–MS detection. Biotins in 
tablets were extracted by the addition of water and ultrasonic agitation. In 
order to clean up the sample solution, the filtrate was applied to an ODS 
cartridge and eluted with methanol. The conditions for preparing the 2-
nitrophenylhydrazide derivatives were modified from a previous report for fatty 
acids. Good recovery rates of over 70% were obtained for the addition of 5–
125 μg of biotin per formulation. The detection limit in HPLC at 400 nm was 
0.6 ng per injection, with good linearity being obtained over the concentration 
range 0.001–0.2 μg per injection. Further, derivatives were determined by 
LC–MS with electrospray ionization, where the spectra indicated the 
molecular ions [M + H] +. The detection limit was 0.025 ng per injection in the 
selected ion monitoring analysis, and linearity was observed in the range of 
0.6–6 ng per injection. The proposed method could be used to specifically 
determine the presence of biotin in relatively clean samples. 
Hua-BinLi et al21., 2001, performed research in ”Simultaneous 
determination of nine water-soluble vitamins in pharmaceutical preparations 
by high-performance liquid chromatography with diode array detection” and 
concluded as a simple and rapid method for the simultaneous determination 
of nine water-soluble vitamins was developed by high performance liquid 
chromatography with diode array detection. The water-soluble vitamins were 
analyzed by HPLC on a μ-Bondapak C18 column (300×3.9 mm, 10 μm) with 
methanol-0.1 mol/L KH2PO4 buffer (pH 7.0) as mobile phase (1.5 mL/min) in 
gradient mode as follows: in the range 0–7.0 min, 10:90; and in the range 
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8.0–15.0 min, 40:60 (v/v). All nine water-soluble vitamins were separated in a 
single HPLC run within less than 15 min. The linearity of the calibration 
graphs was compound-dependent with correlation coefficients of 0.9986 to 
0.9999 (n = 6). The detection limits ranged from 0.02 μg/mL to 0.5 μg/mL. The 
method was successfully applied to the determination of vitamins in 
pharmaceutical preparations. The recoveries were from 95% to 102% and the 
relative standard deviations were in the range of 0.8% to 4.2%. 
Yoon young huh et al22.,  2011,  carried out research in ”Development of 
Analytical Method of Biotin in Complex Drugs and Dietary Supplements Using 
HPLC-UV” and concluded as to improve the quality control, and protect 
consumers by developing prevalently used and efficient analytical tools to 
determine and quantify target compounds. Because the Korean Pharmacopeia 
(KP) presents microbiological assays for biotin, which is laborious and time-
consuming, this study is focused on applying HPLC-UV to detect and quantify 
biotin in complex drugs and dietary supplements like multi-vitamin. Biotin in 
complex drugs was extracted from methanol and analyzed using mobile phase 
with 10 M potassium phosphate (monobasic, pH=3.0) in distilled water and 
acetonitrile. Gradient condition was used to successfully detect and quantify biotin 
within 20 minutes. Validation result for linearity was significant that average r2 was 
0.999 (n=3) and its relative standard deviation (RSD) was 0.0578% which was 
less than 2%. Using this method, quantification of biotin in complex drugs was 
completed successfully and recovery tests were finished that recovery percentage 
greater than 95% with relative standard deviation less than 2%. 
Timmons et al23., 1987 performed research in “Reverse phase liquid 
chromatographic assay for calcium pantothenate in multivitamin preparations 
and raw materials.” A reverse phase liquid chromatographic (LC) method has 
been developed for the assay of calcium pantothenate in commercial 
multivitamin tablet formulations and raw materials. The assay was validated 
according to the Pharmaceutical Manufacturers Association Quality Control 
HPLC Committee guidelines. The chromatographic system includes a C-18 
column and a mobile phase consisting of 0.25M sodium phosphate buffer, pH 
2.5, and acetonitrile (97 + 3 v/v). The column effluent is monitored by UV 
detection at 205 nm. The sample preparation involves only extraction in water 
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followed by filtration. The method is stability-indicating with a detection limit of 
approximately 50 ng/mL of the calcium pantothenate in the samples. The 
system is linear from at least 0.02 to 0.10 mg/mL. The mean recovery of 
spiked placebos ranged from 98.7 to 99.8%. The within-day precision of the 
assay on finished products (N = 6) ranged from 0.3 to 2.0% CV. A system 
suitability criterion for resolution is based on the separation between calcium 
pantothenate and 2 closely eluting compounds, saccharin and a saccharin 
degradation product, 2-sulfamoylbenzoic acid. 
Ramniwas Dudhwal et al24., 2011 carried out research in 
“Simultaneous Estimation of Ascorbic Acid and Calcium Pantothenate in 
Multivitamin and Multimineral Tablets by Reverse-Phase HPLC” and 
concluded as simultaneous estimation of Ascorbic acid (AA)  &  Calcium  
pantothenate  (CP)  in  a  pharmaceutical  Multivitamin  &  Multimineral  unit 
dosage form was achieved on a reverse phase C18 column (5µm; 250x4.6 
mm) with an isocratic mobile phase elution order at a flow rate of 1.0 mL/min. 
The mobile phase was buffer [0.1 %v/v solution of triethylamine in milli-Q 
water with pH 3.00 ± 0.05 (adjusted with ortho-phosphoric acid)] and 
methanol in the ratio of 80:20. Detection was performed with UV detector at 
210nm. The method was validated with respect to linearity, precision, 
accuracy, and specificity according to ICH guidelines. The responses were 
linear in concentration range of 20-60 µg/mL for AA and 2.5-7.5 µg/mL for CP. 
The values of slope and correlation coefficient were  found  to  be  15202  &  
1.000  for  AA;  and  7583  &  1.000  for  CP  respectively.  The %RSD value 
for repeatability and intermediate precision studies were 2.9 & 0.8 for AA; and 
3.3 & 2.8 for CP respectively. The %recovery of the vitamins ranged between 
98.0 to 99.7 for AA and 98.1 to 98.7 for CP. 
Thomas J Hudson et al25., 1984, worked in the area of ”Determination 
of pantothenic acid in multivitamin pharmaceutical preparations by reverse-
phase high-performance liquid chromatography” concluded as a high-
performance liquid chromatographic procedure was developed for the 
analysis of calcium pantothenate in nutritional supplements. The method 
involves a simple extraction using phosphate buffer and sonication. 
Chromatographic separation is obtained using an aminopropyl-loaded silica 
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gel column in the reverse-phase mode. A UV detector set at 210 nm was 
used to monitor the effluent. Quantitative recoveries were obtained, and 
precision of the method is discussed. The method is applicable to multivitamin 
tablets, calcium pantothenate raw material, and yeast grown in the presence 
of high levels of calcium pantothenate. The results of the method are 
compared with results obtained from the USP microbiological method of 
analysis. It was concluded that the procedure is rapid, accurate, easily 
automated, and practical for routine quality control use.  
Kai-On Chu et al26., 1998, carried out research in the area of ”Analysis 
of Commercial Multi-vitamin Preparation by HPLC with Diode Array Detector” 
and reported as a simple and efficient HPLC analysis method has been 
developed to simultaneously analyze complicated multi-vitamin preparations, 
including vitamin B complexes, vitamin C, orotic acid, methionine, calcium 
pantothenate, nicotinamide, biotin, folic acid and rutin, without using 
expensive ion pairing reagent. Diode array detector and adjustment of the 
mobile phase to pH 5.6 are required in the study. This method has been 
validated with good linearity, reproducibility, recovery and accuracy for 
analysis of commercial multi-vitamin products. 
Zerzanova A et al27., 2007, carried out research in ”Using of HPLC 
coupled with coulometric detector for the determination of biotin in 
pharmaceuticals” and concluded as  the method for the determination of biotin 
by high performance liquid chromatography (HPLC) coupled with coulometric 
detector. Chromatographic and detection conditions were tested. A 
LiChrospher 60RP-select B column (250 mm × 4 mm; 5 μm) and the mobile 
phase containing 0.24 mol/L aqueous solution of acetic acid and acetonitrile in 
the ratio 85:15 (v/v) were found as the most suitable. The flow rate was 
1 mL/min and the injected volume of the sample was 20 μL. The 
hydrodynamic voltammogram of biotin was measured and according to 
obtained data the detection parameters were set – channel I 600 mV, channel 
II 900 mV, sensitivity 1 μA. The developed method has been validated. The 
calibration curve is linear in the range 15–3600 ng/mL, correlation coefficient 
is 0.9998, limits of detection and quantification are 5 and 15 ng/mL, 
respectively. Recovery of the spiked samples was 98.67% with RSD 0.255% 
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on average. The developed method has been successfully applied for 
determination of biotin in pharmaceutical preparations. 
Staggs C G et al28., 2004, carried out research in ”Determination of the 
biotin content of select foods using accurate and sensitive HPLC/avidin 
binding” and reported as accuracy in estimating dietary biotin is limited both 
by data gaps in food composition tables and by inaccuracies in published 
data. The present study applied sensitive and specific analytical techniques to 
determine values for biotin content in a select group of foods. Total biotin 
content of 87 foods was determined using acid hydrolysis and the 
HPLC/avidin-binding assay. These values are consistent with published 
values in that meat, fish, poultry, egg, dairy, and some vegetables are 
relatively rich sources of biotin. However, these biotin values disagreed 
substantially with published values for many foods. Assay values varied 
between 247 times greater than published values for a given food to as much 
as 36% less than the published biotin value. Among 51 foods assayed for 
which published values were available, only seven agreed within analytical 
variability (±20%). We conclude that published values for biotin content of 
foods are likely to be inaccurate. 
Pei chen et al29., 2010 carried out research in “A LC/UV/Vis method for 
determination of cyanocobalamin (VB12) in multivitamin dietary supplements 
with on-line sample clean-up” and concluded that the HPLC- UV/Vis method 
using a two-column strategy with a switching valve for on-line sample clean-
up was developed by using two columns (i.e) Agilent zorbax C8 (150mm× 
4.6mm, 5µm particle size) reverse phase column and a waters symmetry C18 
(150mm× 4.6mm, 5µm particle size) reverse phase column. Chromatographic 
separation was achieved using a programmed gradient mobile phase 
consisting of (A) 0.1% formic acid in acetronitrile. Because of the low levels of 
vitamin-B12 in the sample, large injection volumes, and thus much interfering 
material, must be used to exceed the limit of quantification (LOQ) by UV 
detection. A switching valve was used to divert most of these early eluting 
interfering materials to waste, effecting online sample cleanup without 
excessive sample preparation steps. The recovery of CN-Cbl in the method 
was 99.5% and the LOQ was 10ng per injection. The method was 
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successfully applied to the analysis of the NIST SRM 3280 multivitamin/ 
multimineral dietary supplement tablet. The method is specific, precise and 
accurate for the intended use. Compared to off-line sample clean-up 
procedures, it offers the advantage of being easier, more economical and less 
time consuming. 
Gabriela Klaczkow et al30., 2001, developed method for “Elaboration of 
HPLC method for Biotin determination in multiple vitamin drugs and 
comparison with microbiological method” and reported the optimal analytical 
conditions for the biotin determination by HPLC method with detection at the 
wavelength 200 nm in multiple vitamin drugs. Statistical parameters of the 
HPLC method and the microbiological method of the biotin determination 
were compared whose RSD values were 0.31%-1.88%and 2.02%-6.63% 
respectively. 
Tsui-Min Wang et al31., 2003, performed research in “Liquid 
chromatographic method for determination of calcium pantothenate 
preparations and related stability studies” and reported that the samples were 
analyzed in C18 column with the mobile phase of acetonitrile and potassium 
dihydrogen phosphate solution pH adjusted to 2.5 with phosphoric acid at the 
flow rate of 1.0 mL/min and UV absorbance detection at 204 nm. Ampicilin 
was used as a internal standard. The retention time of calcium pantothenate 
and ampicilin were 5.3 and 6.5 min, respectively. An equation was presented 
for linear relationship between peak height ratios of calcium pantothenate to 
ampicilin and the calcium pantothenate concentration over a range of 10-50 
µg/ml (r = 0.9999). Standard addition recoveries were greater than 98.96% 
with twelve commercial products. The RSD were lies between 0.1 and 0.9% in 
inter-day assays, 0.1 and 0.7% in intra-day assays. The result obtained from 
the HPLC assay method which we developed and the microbiological assay 
of USP was paired at 95% confidence level. There was no significant 
difference between these two methods. The proposed HPLC method was a 
suitable substitute for microbiological method for quantitative assays of 
calcium pantothenate in commercial products. 
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Marina Franco et al32., 2011, carried out research in “Application of 
CZE method in routine analysis for determination of B-complex vitamins in 
pharmaceutical and veterinary preparations” and concluded that vitamins of 
interest are thiamine hydrochloride (B1), thiamine monophosphate chloride 
(B1a), ribofavine (B2), riboflavin-5’ monophosphate (B2a), nicotinamide (B3), d- 
pantothenic acid calcium salt (B5), pyridoxine hydrochloride (B6), folic acid (B9) 
and 4-amino benzoic acid (B10). These analytes were separated optimizing 
the experimental condition in 20mM tetra borate buffer pH = 9.2 as a BGE, on 
Beckman P/ACE system MDQ instrument, using uncoated fused silica 
capillary. The effective capillary length was of 49.5 cm, I.D. = 50µm, the 
applied voltage 20kV and the temperature 25ºc. Detection was performed by 
diode array detector at 214 nm for all vitamins except B5 (190nm) and B2a 
(260 nm). Separation time was about 9 min. After experimental conditions 
optimization, the proposed method was validated. Precision of migration time 
and corrected peak area, linearity range, LOD and LOQ, accuracy (recovery), 
robustness and ruggedness were evaluated for each analyte demonstrating 
the good reliability of the method. Analysis of the pharmaceutical real samples 
was performed and confirmed the versatility of this method.  
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RESEARCH OBJECTIVE 
The drug analysis plays an important role in the development of drugs, 
their manufacture and the therapeutic use.  Pharmaceutical industries rely 
upon quantitative chemical analysis to ensure that the raw materials used and 
final product obtained meets the required specification. The number of drugs 
and drug formulations introduced in to the markets has been increased at an 
alarming rate. These drugs or formulation may be either in the new entities in 
the market or partial structure modification of the existing drugs or novels 
dosage forms or multi component dosage forms.  
The drug selected for the present study is biotin and calcium 
pantothenate in tablet dosage form containing multi-vitamins and multi-
minerals. A review of literature reveals that only few chromatographic and 
spectrophotometric methods have been reported for the estimation of biotin 
and calcium pantothenate separately but not in simultaneous method. So my 
prime aim is to develop a simple, rapid, efficient, accurate, reproducible, less 
time consuming and reliable new validated chromatographic method of 
analysis for biotin and calcium pantothenate in pharmaceutical dosage form. 
The objective of the research is as follows: 
 Development of rapid, sensitive and accurate reverse phase HPLC 
method for the simultaneous estimation of biotin and calcium 
pantothenate. 
 To estimate biotin and calcium pantothenate simultaneously from 
tablet dosage form by developed method and validation of 
proposed method. 
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PLAN OF RESEARCH WORK 
 
1. To collect through knowledge in practical RP-HPLC method 
development by using various search engines like ACS, Elsevier, 
Bentham, etc… 
 
2. To proceed a step by step procedure for method development to be 
implemented and initial chromatographic condition for assay of biotin 
and calcium pantothenate in tablet dosage form is to be estimated. 
 
 
3. To optimize the chromatographic conditions and trials the method. 
 
4. To validated a method for analytical quantization of assay in biotin and 
calcium pantothenate in tablets dosage form. 
 
 
5. To give a general ICH guidelines for the validation of methods aim for 
the quantization of biotin and calcium pantothenate in tablets dosage 
form. 
 
6. To make document from the obtained results with improved accuracy 
and precision. 
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DRUG PROFILE 
Biotin: 
Biotin is a water-soluble B-vitamin, also called vitamin B7 and formerly 
known as vitamin H or coenzyme R. Biotin is necessary for cell growth, the 
production of fatty acids, and the metabolism of fats and amino acids.  Biotin 
assists in various metabolic reactions involving the transfer of carbon dioxide. 
It may also be helpful in maintaining a steady blood sugar level. Biotin is often 
recommended as a dietary supplement for strengthening hair and nails, 
though scientific data supporting this outcome are weak.  Nevertheless, biotin 
is found in many cosmetics and health products for the hair and skin. 
Synonym  : Vitamin B7; Vitamin H; Coenzyme R; Biopeiderm 
Empirical 
Formula        
: C10H16N2O3S 
Molecular weight          : 244.31 g·mol−1 
Appearance                  : White crystalline needles 
Melting Point               : 232 to 233 °C (450 to 451 °F; 505 to 506 K) 
Solubility in 
water        
: 22 mg/100ml 
Structure : 
 
5-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl) 
pentanoic acid 
 
                                                
S
NH NH
O
O
OH
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Calcium Pantothenate: 
Pantothenic acid, also called vitamin B5 (B vitamin), is a water-
soluble vitamin. Pantothenic acid is an essential nutrient. Animals require 
pantothenic acid to synthesize coenzyme-A (CoA), as well as to synthesize 
and metabolize proteins, carbohydrates and fats. The anion is called  
pantothenate. Pantothenic acid in the form of CoA is also required for 
acylation and acetylation, which, for example, are involved in signal 
transduction and enzyme activation and deactivation, respectively. Since 
pantothenic acid participates in a wide array of key biological roles, it is 
essential to all forms of life.  As such, deficiencies in pantothenic acid may 
have numerous wide-ranging effects. Calcium pantothenate is often used in 
dietary supplements because, as a salt, it is more stable than pantothenic 
acid. Supplementation may improve oxygen utilization efficiency and reduce 
lactic acid accumulation in athletes. 
Molecular formula : C9H17NO5 
Molecular weight : 476.536 g/mol 
Appearance  : Yellow oil ; Colorless crystals (Ca2+ salt) 
Melting point  : 183.83 °C (362.89 °F; 456.98 K)                                                                                      
Solubility 
   
:  Very soluble in C6H6, ether; Ca2+ salt: Slightly soluble 
in alcohol, CHCl3. 
Solubility in Water         : Very soluble 2.11 g/mL (Ca2+ salt) 
Related Compound         : Panthenol  
Structure : 
 
Calcium salt of 3-[(2,4-dihydroxy-3,3-
dimethylbutanoyl)amino]propanoic acid 
OH CH3CH3
OH O
NH
O
OH
Ca
2+
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MATERIALS AND EQUIPMENTS 
Background: 
            The RP-HPLC method for the estimation of biotin and calcium 
pantothenate in solid dosage form has been validated in Fourrts (India) 
Laboratories Pvt. Ltd.  Analytical method validation for the estimation of biotin 
and calcium pantothenate in solid dosage form by RP-HPLC has been 
conducted as per the protocol, to ensure that the performance characteristics 
of the method meet the requirements for its intended application. 
Required instrument and reagent: 
Materials:  
            The following table list materials were used in this study. 
S.No Name Grade Supplier 
Lot No/ 
B.No 
Purity Expiry 
1 KH2PO4 AR 
Rankem, RFCL 
Ltd, Mumbai. 
J037C16 100.0% Feb’20 
2 KH2PO4 AR 
Finar Chemical 
Ltd, Sanand. 
21070305J12 99.5% Oct’17 
3 Methanol HPLC 
Fischer 
Chemicals.  
1333170916 99.9% Oct’18 
4 Methanol HPLC 
Finar Chemical 
Ltd, Sanand. 
168071027AP 99.8% Jun’18 
5 H3PO4 AR 
Rankem, RFCL 
Ltd, Mumbai. 
G025J15 88.0% Sep’18 
6 Ammonia AR 
Fischer 
Chemicals.  
4929/17306-5 25.0% Jun’17 
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Working standard:           
            The following table list standards were used in this study. 
S.No Name Grade Lot No/ B.No Purity Expiry 
1 Calcium pantothenate BP WS038/09 97.75 23/10/2017 
2 Biotin BP WS103/07 99.35 09/02/2018 
 
Instrumentation:  
           The following table list instruments were used in this study. 
S.No Name of the Instrument Ref. Number Make Model 
1 Electronic balance I/RD/OEB/EB/01 
Adventurer 
OHAUS 
AR2140 
2 HPLC I/RD/HPC/02 Shimadzu Prominence 
3 HPLC I/RD/HPC/04 Shimadzu LC-2010C HT 
 
Column details: 
            The following table list column that was used in this study. 
Column 
Ref. 
Number 
I.D. Number Make Specification 
1 RD/COL/76 K63402 
Nacalai 
Tesque,Inc. 
Cosmosil ,5C18-MS-II 
(250 X 4.6 mm, 5µ) 
2 RD/COL/77 K65386 
Nacalai 
Tesque,Inc. 
Cosmosil ,5C18-MS-II 
(250 X 4.6 mm, 5µ) 
 
  
  
CHAPTER 6: 
EXPERIMENTAL 
WORKS 
EXPERIMENTAL WORKS    
Dept. of Pharmaceutical Analysis 
Arulmigu Kalasalingam College of Pharmacy Page 29 
EXPERIMENTAL WORKS – (RP- HPLC) 
Method development 
1. Selection of wavelength: 
            Biotin and calcium pantothenate working standards were dissolved in 
suitable diluent. And the solution were scanned between 200 to 400 nm using 
uv-visible spectrophotometer then these were subjected to chromatograph 
containing PDA detector to determine the accurate and optimized wavelength. 
After reviewing the uv-visible Spectrum, a wavelength of 210 nm was 
selected as the optimum wavelength for this method. 
2. Selection of Mobile phase: 
            A mobile phase of water: methanol in the ratio of 1:1 was run through 
the HPLC column. But the elution of drug in this mobile phase was poor. So, 
mobile phase was changed to mono basic potassium dihydrogen 
orthophosphate buffer and methanol in the ratio of 1:1 with pH of 4, again the 
elution was poor. So, the concentration of same mobile phase was changed 
to 60: 40 (buffer: methanol) and adjusts the pH 2.20 ± 0.05 with 10% 
orthophosphoric acid and it was used. 
3. Buffer preparation: 
            Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate 
in 1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter.  
4. Mobile phase preparation: 
            Measure 600ml of buffer and 400ml of methanol to form the 
concentration ratio of 60:40, mix well and degas it. 
5. Standard solution (Calcium pantothenate): 
           Weigh accurately about 100.0 mg of calcium pantothenate working 
standard into a clean 100 ml volumetric flask. Dissolve in 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water (Concentration: 1.0 mg/ml of calcium pantothenate). 
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6. Standard solution (Biotin): 
           Weigh accurately about 10.0 mg of biotin working standard into a clean 
100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia 
solution. Sonicate for 5 minute, and make up the volume with the water 
(Concentration: 0.10 mg/ml of biotin). 
7. Standard Solution (Calcium pantothenate+ biotin): 
           Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 1.0 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
Chromatographic conditions:  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (60: 40) 
Report: 
           It shows elution but the peak was not splitted in combined form. 
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For improving the elution of biotin and calcium pantothenate in 
combination: 
           The peaks of biotin and calcium pantothenate were not separated in 
the combined form. In order to separate peaks either change in ratio of mobile 
phase or addition of peak modifier or ion pairing agent has to be used. Here 
changing the buffer concentration should be used to its ability to shift peak in 
the ratio of 70:30 (buffer: methanol) and thus giving good resolution. 
Buffer preparation: 
           Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter.  
 Mobile phase preparation: 
           Measure 700ml of buffer and 300ml of methanol to form the 
concentration ratio of 70:30, mix well and degas it. 
Standard solution (Calcium pantothenate): 
          Weigh accurately about 100.0 mg of calcium pantothenate working 
standard into a clean 100 ml volumetric flask. Dissolve in 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water (Concentration: 1.0 mg/ml of calcium pantothenate). 
Standard solution (Biotin): 
         Weigh accurately about 10.0 mg of biotin working standard into a clean 
100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia 
solution. Sonicate for 5 minute, and make up the volume with the water 
(Concentration: 0.10 mg/ml of biotin). 
Standard solution (Calcium pantothenate+ biotin): 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of Biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 1.0 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
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Chromatographic conditions:  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
Report: 
         Elution of both biotin and calcium pantothenate was found to be 
extremely good when change in concentration of mobile phase was used. 
Selection of phase:  
         On the basis of RP-HPLC mode and number of carbon atom present in 
molecule C18 bonded stationary phase was tried. Cosmosil, C18, 250 X 4.6 
mm, 5 μm or equivalent, for this stationary phase was selected as it gives 
good result in case of system suitability parameter i.e. resolution, USP 
tangent, USP tailing. 
Selection of other parameter: 
        Other parameter like mobile phase, flow rate, column, temperature and 
wavelength of detector can be selected on the basis of chemical properties of 
components present in the sample, sensitivity and system suitability 
requirement of the analytical method. 
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OPTIMIZED METHOD 
Buffer preparation: 
Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45μ membrane filter.  
 Mobile phase preparation: 
Measure 700ml of buffer and 300ml of methanol to form the 
concentration ratio of 70:30, mix well and degas it. 
Standard solution (Calcium pantothenate): 
Weigh accurately about 100.0 mg of calcium pantothenate working 
standard into a clean 100 ml volumetric flask. Dissolve in 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water (Concentration: 1.0 mg/ml of calcium pantothenate). 
Standard solution (Biotin): 
Weigh accurately about 10.0 mg of biotin working standard into a clean 
100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia 
solution. Sonicate for 5 minute, and make up the volume with the water 
(Concentration: 0.10 mg/ml of biotin). 
Standard solution (Calcium pantothenate+ biotin): 
Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 1.0 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
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Chromatographic conditions:  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
Calculation: 
% Assay of calcium pantothenate: 
            Area of sample X Std wt (mg) X 100 X Purity of std. X Avg wt. of tablet (mg) X 100 
  =             ---------------------------------------------------------------------------------------- 
                       Area of std X 100 X Sample wt (mg) X 100 X 100 
 
 
  =              --------------- % of calcium pantothenate  
% Assay of biotin: 
Area of sample X Std wt (mg) X 100 X Purity of std. X Avg wt. of tablet (mg) X 100 
 =             ------------------------------------------------------------------------------------------------- 
                       Area of std X 100 X Sample wt (mg) X 100 X 10 
 
 =               --------------- % of biotin  
Parameters used for assay validation: 
        The validation of the assay procedure was carried out using the following 
parameters. 
1. Specificity: 
        Analyze the placebo, calcium pantothenate and biotin separately. A 
solution of placebo was spiked with the calcium pantothenate and biotin at its 
working concentration. The solution was analyzed as per the RP-HPLC 
method described.  
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        (i) Placebo solution:  
                  Weigh accurately about 430 mg of powdered placebo into a clean 
100 ml volumetric flask.  Add 25 ml of water and 0.2 ml of ammonia solution. 
Sonicate for 5 minute, and make up the volume with the water and filter 
(Concentration: 4.30 mg/ml of placebo). 
        (ii) Standard solution (Calcium pantothenate): 
                  Weigh accurately about 100.0 mg of calcium pantothenate working 
standard into a clean 100 ml volumetric flask.  Dissolve in 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water (Concentration: 1.0 mg/ml of calcium pantothenate).      
        (iii) Standard solution (Biotin): 
                  Weigh accurately about 10.0 mg of biotin working standard into a 
clean 100ml volumetric flask.  Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 0.10 mg/ml of biotin). 
        (iv) Standard solution (Calcium pantothenate + biotin): 
                  Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask.  Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 1.0 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (v) Standard + placebo solution: 
                 Weigh accurately about 430.0 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of Placebo, 1.0 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin). 
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Acceptance criteria: 
        The placebo chromatogram should not show any peak at the retention 
time of calcium pantothenate and biotin. 
2. System precision: 
        A standard solution of 1.00 mg/ml of calcium pantothenate, and 0.10 
mg/ml of biotin was prepared and analyzed as per the method. 
        (i) Standard solution: 
                 Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 1.0 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
Procedure: 
        Inject the standard solution (6 injections). Ensure the following system 
suitability criteria. Table 6.1 expresses the criteria for system precision. 
Table 6.1: Acceptance criteria 
System suitability parameter Acceptance criteria 
Tailing factor NMT 2.0 
Column efficiency NLT 2000 theoretical plates 
Relative standard deviation NMT 2.0% 
 
3. Linearity and Range: 
        (a) Linearity of Calcium pantothenate: 
                 The linearity of the RP-HPLC method was demonstrated for 
calcium pantothenate ranging from 0.4960 mg/ml to 1.4940 mg/ml, which is 
equivalent to 50% to 150% of the calcium pantothenate working strength. Five 
standard solutions at the concentrations within the mentioned range were 
prepared and analyzed as per the method. 
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       (b) Linearity of biotin: 
                 The linearity of the RP-HPLC method was demonstrated for biotin 
solutions ranging from 0.0520 mg/ml to 0.1500 mg/ml, which is equivalent to 
50% to 150% of the biotin working strength. Five standard solutions at the 
concentrations within the mentioned range were prepared and analyzed as 
per the method. 
Solutions:  
        (i) Level - I (50%): 
                 Weigh accurately about 50.0 mg of calcium pantothenate working 
standard and 5.0 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 0.50 mg/ml 
of calcium pantothenate and 0.05 mg/ml of biotin). 
        (ii) Level - II (80%): 
                 Weigh accurately about 80.0 mg of calcium pantothenate working 
standard and 8.0 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water (Concentration: 0.80 mg/ml 
of calcium pantothenate and 0.08 mg/ml of biotin). 
        (iii) Level - III (100%): 
                 Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10.0 mg of biotin working standard into a clean 100 ml 
volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. 
Sonicate for 5 minute, and make up the volume with the water (Concentration: 
1.00 mg/ml of calcium pantothenate and 0.10 mg/ml of biotin). 
        (iv) Level – IV (120%): 
                 Weigh accurately about 120.0 mg of calcium pantothenate working 
standard and 12.0 mg of biotin working standard into a clean 100 ml 
volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. 
Sonicate for 5 minute, and make up the volume with the water (Concentration: 
1.20 mg/ml of calcium pantothenate and 0.12 mg/ml of biotin). 
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        (v) Level – V (150%): 
                 Weigh accurately about 150.0 mg of calcium pantothenate working 
standard and 15.0 mg of biotin working standard into a clean 100 ml 
volumetric flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. 
Sonicate for 5 minute, and make up the volume with the water (Concentration: 
1.50 mg/ml of calcium pantothenate and 0.15 mg/ml of biotin). 
Procedure: 
        Prepare the above solutions ranging from 50% to 150% and inject each 
level in duplicate.    
         Perform the Correlation co-efficient by covering at least five points and 
report the linearity as the range for determining the assay. 
Acceptance criteria:  
        The plot of concentration versus peak area should be linear with a 
correlation co- efficient not less than 0.995. 
4. Accuracy: 
        The accuracy of the method was determined by using three solutions 
containing placebo spiked with calcium pantothenate and biotin at 
approximately 50%, 100% and 150% of its working strength. Each level was 
analyzed. 
 Solutions: 
        (i) Level - I (50%) – 1: 
                 Weigh accurately about 430 mg of placebo, 50.0 mg of calcium 
pantothenate working standard and 5.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 0.50 mg/ml of calcium 
pantothenate and 0.05 mg/ml of biotin). 
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        (ii) Level - I (50%) – 2: 
                 Weigh accurately about 430 mg of placebo, 50.0 mg of calcium 
pantothenate working standard and 5.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 0.50 mg/ml of calcium 
pantothenate and 0.05 mg/ml of biotin). 
        (iii) Level - I (50%) – 3: 
                 Weigh accurately about 430 mg of placebo, 50.0 mg of calcium 
pantothenate working standard and 5.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 0.50 mg/ml of calcium 
pantothenate and 0.05 mg/ml of biotin). 
        (iv) Level - II (100%) – 1: 
                 Weigh accurately about 430 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.00 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin). 
        (v) Level – II (100%) – 2: 
                 Weigh accurately about 430 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.00 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin). 
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        (vi) Level – II (100%) – 3: 
                 Weigh accurately about 430 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10.0 mg of Biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.00 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin). 
        (vii) Level – III (150%) – 1: 
                 Weigh accurately about 430 mg of placebo, 150.0 mg of calcium 
pantothenate working standard and 15.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.50 mg/ml of calcium 
pantothenate and 0.15 mg/ml of biotin). 
        (viii) Level – III (150%) – 2: 
                 Weigh accurately about 430 mg of placebo, 150.0 mg of calcium 
pantothenate working standard and 15.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.50 mg/ml of calcium 
pantothenate and 0.15 mg/ml of biotin). 
        (ix) Level – III (150%) – 3: 
                 Weigh accurately about 430 mg of placebo, 150.0 mg of calcium 
pantothenate working standard and 15.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.50 mg/ml of calcium 
pantothenate and 0.15 mg/ml of biotin). 
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Procedure 
        Prepare the above solutions in the range of from 50%, 100% and 150% 
and inject each solution in duplicate as per the test method.    
        Calculate the recovery in each level by calculating the measured 
concentration against theoretical concentration. 
Acceptance criteria:  
        The recovery should be in the range of 98.0-102.0% 
5. Method precision: 
        The method precision was performed by analyzing a sample solution of 
Hairgro tablets (B.No: RD16047) as per the test method (six replicate sample 
preparation).  
Solutions: 
        (i) Standard solution: 
                 Weigh accurately about 430 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.00 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin).  
        (ii) Test solution - 1:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
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        (iii) Test solution - 2: 
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (iv) Test solution - 3:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (v) Test solution – 4: 
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (vi) Test solution - 5:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (vii) Test solution - 6:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter. (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin) 
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Procedure: 
        Prepare the test solution of Hairgro tablets as per the test method and 
inject each solution. Calculate the precision of the method by calculating % 
assay of each solution against standard solution. Report the % RSD of all 
individual assay values. 
Acceptance criteria: 
        The percentage relative standard deviation for the assay values should 
be less than 2.0. 
6. Ruggedness (Intermediate precision) 
        The ruggedness of the method was performed by analyzing a sample 
solution of Hairgro tablets (B.No:RD16047) as per the test method (six 
replicate sample preparation) and injected each solution in duplicate using 
different instrument, column, reagent, and analyst on different days. The 
results of set I were compared with the results of set II. 
Table 6.2 
Parameter Set I Set II 
Instrument to instrument Instrument – 1 Instrument – 2 
Column to column Column – 1 Column – 2 
Reagent to reagent Reagent – 1 Reagent – 2 
Analyst to analyst Analyst – 1 Analyst – 2 
Day to day Day – 1 Day – 2 
 
Solutions: 
        (i) Standard solution: 
                 Weigh accurately about 430 mg of placebo, 100.0 mg of calcium 
pantothenate working standard and 10.0 mg of biotin working standard into a 
clean 100 ml volumetric flask. Dissolve in 25 ml of water and 0.2 ml of 
EXPERIMENTAL WORKS    
Dept. of Pharmaceutical Analysis 
Arulmigu Kalasalingam College of Pharmacy Page 44 
ammonia solution. Sonicate for 5 minute, and make up the volume with the 
water (Concentration: 4.30 mg/ml of placebo, 1.00 mg/ml of calcium 
pantothenate and 0.10 mg/ml of biotin). 
        (ii) Test solution - 1:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (iii) Test solution - 2: 
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin).     
        (iv) Test solution - 3:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (v) Test solution – 4: 
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
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        (vi) Test solution - 5:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
        (vii) Test solution - 6:  
                 Weigh and finely powder 20 tablets. Weigh accurately about 540 
mg of powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of 
water and 0.2 ml of ammonia solution. Sonicate for 5 minute, and make up 
the volume with the water and filter (Concentration: Equivalent to 1.00 mg/ml 
of calcium pantothenate and 0.10 mg/ml of biotin). 
Procedure: 
        Prepare the test solution of Hairgro tablets by different analyst with 
different reagent on different day as per the test method. Inject each solution 
with different instrument using different column, different reagent, different 
analyst and different days. 
Calculate the ruggedness of the method by calculating % assay of 
each solution against standard solution.  
Report the overall % RSD of all individual assay values in set-I and 
set–II. 
Acceptance criteria: 
        The overall % RSD should not be more than 2.0%. 
7. Robustness 
        The following table (Table 6.3) shows the parameters of the method that 
were altered to test the robustness of the method. The robustness of the 
method is to be determined by analyzing the standard solution six times with 
varying RP-HPLC conditions as described below. Table 6.4 expresses the 
criteria for robustness 
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Table 6.3:   Parameters altered for robustness test 
Parameter  Actual Low High 
Flow rate 1.00 ml/min 0.90 ml/min 1.10 ml/min 
Mobile Phase ratio 70 :  30 72 :  28 68 :  32 
Buffer pH 2.20 2.10 2.30 
Column oven temperature 30°C 28°C 32°C 
 
Table 6.4: Acceptance criteria 
System suitability parameter Acceptance criteria 
Tailing factor NMT 2.0 
Column efficiency NLT 2000 theoretical plates 
Relative standard deviation NMT 2.0% 
 
7.1 Chromatographic conditions (Actual):   
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30)      
           Preparation of buffer:    
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter. 
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Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of Biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water.  
Test Solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
7.2 Chromatographic conditions (Flow-Low): 
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or Equivalent 
Flow rate   : 0.9 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
 Preparation of buffer:    
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid.  Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
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Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask.  Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
7.3 Chromatographic conditions (Flow-High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.1 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
 Preparation of buffer:  
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
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7.4 Chromatographic conditions (Mobile Phase – Ratio - Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (72: 28) 
Preparation of buffer:   
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid.  Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter.  
7.5 Chromatographic conditions (Mobile Phase – Ratio - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
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Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (68: 32) 
Preparation of buffer:    
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
 7.6 Chromatographic conditions (Buffer pH - Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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 Preparation of buffer:    
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.10   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
Test solution 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
7.7 Chromatographic conditions (Buffer pH - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
Preparation of buffer:  
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.30   0.05 with 10 % orthophosphoric 
acid.  Filter through 0.45 μ membrane filter. 
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Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water.  
Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
7.8 Chromatographic conditions (Column Oven Temperature - Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 28°C 
Mobile phase  : Buffer: methanol (70: 30) 
Preparation of buffer:   
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid. Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water.  
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Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
7.9 Chromatographic conditions (Column Oven Temperature - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 32°C 
Mobile phase  : Buffer: methanol (70: 30) 
           Preparation of buffer:  
         Dissolve 4.1 g of mono basic potassium dihydrogen ortho phosphate in 
1000 ml of water. Adjust the pH to 2.20   0.05 with 10 % orthophosphoric 
acid.  Filter through 0.45 μ membrane filter. 
Standard solution: 
         Weigh accurately about 100.0 mg of calcium pantothenate working 
standard and 10 mg of biotin working standard into a clean 100 ml volumetric 
flask. Dissolve in 25 ml of water and 0.2 ml of ammonia solution. Sonicate for 
5 minute, and make up the volume with the water. 
Test solution: 
         Weigh and finely powder 20 tablets. Weigh accurately about 540 mg of 
powdered tablets into a clean 100 ml volumetric flask. Add 25 ml of water and 
0.2 ml of ammonia solution. Sonicate for 5 minute, and make up the volume 
with the water and filter. 
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8. Solution Stability 
         Measure the stability of the Hairgro tablets test solution against 100% of 
the standard concentration by keeping the solution up to 48 hours at 15C. 
Inject the sample at different time intervals (i.e: Initial, 6, 12, 18, 24, 36& 48 
hours) and calculate the percentage relative standard deviation of calcium 
pantothenate and biotin in Hairgro tablets at different interval of time. 
Acceptance Criteria: 
         The overall % RSD should not be more than 2.0%. 
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RESULTS  
1. Specificity: 
         Placebo solution was prepared separately at a concentration of 4.3 
mg/ml with matrix blend. Calcium pantothenate was prepared at its working 
concentration and analyzed as per the method. Biotin was prepared at its 
working concentration and analyzed as per the method. A typical 
chromatogram for specificity is shown in Figure- 7.1 - 7.6. Table 7.1 
Summarizes the retention time and relative retention time values for placebo 
peaks, calcium pantothenate and biotin. 
 
Figure 7.1: Chromatogram of blank 
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Figure 7.2: Chromatogram of placebo 
 
 
Figure 7.3: Chromatogram of calcium pantothenate 
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Figure 7.4: Chromatogram of biotin 
 
 
 
Figure 7.5: Chromatogram of standard 
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Figure 7.6: Chromatogram of standard + placebo 
Table 7.1: Summary of retention time and relative retention time values for 
placebo peaks, calcium pantothenate and biotin. 
Peak name 
Retention time 
(minutes) 
  Relative 
retention time 
Blank peak 3.43 0.35 
Calcium pantothenate 4.53 0.46 
Biotin 9.79 1.00 
           
          No peak was observed at the retention time of calcium pantothenate 
and biotin in the chromatogram of placebo. 
2. System precision: 
          A standard solution of 1.00 mg/ml of calcium pantothenate, and 0.10 
mg/ml of biotin was prepared and analyzed as per the method. Inject the 
standard solution (6 injections). Ensure the following system suitability criteria. 
A typical chromatogram for system precision is shown in Figure-7.7. Table 
7.2: Summarizes the Retention time, % RSD of peak area, tailing factor and 
theoretical plates of the calcium pantothenate peak. Table 3: Summarizes the 
retention time, % RSD of peak area, tailing factor and theoretical plates of the 
biotin Peak 
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Figure 7.7: Chromatogram of system precision 
Table 7.2: Summary of retention time, % RSD of peak area, tailing factor 
and theoretical plates of the calcium pantothenate peak 
S.No 
Retention 
time 
(Minutes) 
Area 
Tailing 
factor 
Theoretical 
plates 
1 4.32 4966028 
1.23 8638 
2 4.31 4987693 
3 4.40 4988008 
4 4.31 4983644 
5 4.32 4981030 
6 4.30 5003737 
Average 4985023 
% RSD 0.24 
 
          The percentage relative standard deviation of peak area of calcium 
pantothenate was 0.24 with the tailing factor and theoretical plates of 1.23 and 
8638 respectively. 
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Table 7.3: Summary of retention time, % RSD of peak area, tailing factor 
and theoretical plates of the biotin peak 
S.No 
Retention 
time 
(Minutes) 
Area 
Tailing 
factor 
Theoretical 
plates 
1 9.10 737506 
1.05 14392 
2 9.11 744892 
3 9.15 740429 
4 9.27 745914 
5 9.09 735393 
6 9.14 736349 
Average 740081 
% RSD 0.60 
          
      The percentage relative standard deviation of peak area of biotin was 
0.60 with the tailing factor and theoretical plates of 1.05 and 14392 
respectively. 
3. Linearity and Range: 
     (a) Linearity of calcium pantothenate 
               The linearity of the RP-HPLC method was demonstrated for 
calcium pantothenate ranging from 0.4960 mg/ml to 1.4880 mg/ml, which 
is equivalent to 50% to 150% of the calcium pantothenate working 
strength. Five standard solutions at the concentrations within the 
mentioned range were prepared and analyzed as per the method. The 
linearity results obtained are shown in Table 7.4. Figure 7.13 shows the 
line of best fit for peak area versus concentration of biotin. 
     (b) Linearity of biotin 
               The linearity of the RP-HPLC method was demonstrated for 
biotin solutions ranging from 0.05200 mg/ml to 0.15000 mg/ml, which is 
equivalent to 50% to 150% of the biotin working strength. Five standard 
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solutions at the concentrations within the mentioned range were prepared 
and analyzed as per the method. The linearity results obtained are shown 
in Table 7.5. Figure 7.14 shows the line of best fit for peak area versus 
concentration of biotin. A typical chromatogram for linearity is shown in 
Figure- 7.8-7.12 
 
Figure 7.8: Chromatogram of linearity-50% 
 
 
Figure 7.9: Chromatogram of linearity – 80% 
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Figure 7.10: Chromatogram of linearity – 100% 
 
 
Figure 7.11: Chromatogram of linearity – 120% 
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Figure 7.12: Chromatogram of linearity – 150% 
 
Table 7.4: Linearity of calcium pantothenate 
Level % of CP  working strength Conc (mg/ml) Peak area 
50% 49.6 0.4960 2702601 
80% 80.3 0.8030 4162205 
100% 100.8 1.0090 5122685 
120% 119.4 1.1940 5859779 
150% 148.8 1.4880 7028796 
Correlation coefficient 0.9976 
 
Figure 7.13: Linearity graph for calcium pantothenate 
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          Thus, the RP-HPLC method for the estimation of calcium pantothenate 
in Hairgro tablets was shown to be linear in the range of 50% to 150% of the 
working concentration with a correlation coefficient of 0.9976. The range of 
the RP-HPLC method for determining the assay of calcium pantothenate in 
Hairgro tablets is 50% to 150% of the working strength. 
Table 7.5: Linearity of biotin 
Level % of  BI working strength Conc (mg/ml) Peak area 
50% 52.0 0.05200 389460 
80% 83.0 0.08300 621587 
100% 102.0 0.10200 768768 
120% 121.0 0.12100 929599 
150% 150.0 0.15000 1154724 
Correlation coefficient 0.9997 
 
Figure7.14: Linearity graph for biotin 
 
 
          Thus, the RP-HPLC method for the estimation of biotin in Hairgro 
tablets was shown to be linear in the range of 50% to 150% of the working 
concentration with a Correlation coefficient of 0.9997. The range of the RP-
HPLC method for determining the assay of Biotin in Hairgro tablets is 50% to 
150% of the working strength. 
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4. Accuracy: 
         The accuracy of the method was determined by using three solutions 
containing placebo spiked with calcium pantothenate and biotin at 
approximately 50%, 100% and 150% of its working strength. Each level was 
analyzed as per the method. A typical chromatogram for accuracy is shown in 
Figure 7.15 – 7.17 
 
Figure7.15: Chromatogram of accuracy – 50% 
 
Figure7.16: Chromatogram of accuracy –100% 
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Figure7.17: Chromatogram of accuracy –150 
Table 7.6: Accuracy of calcium pantothenate 
Level 
%CP Working 
strength 
Theoretical 
Conc (mg/ml) 
Measured 
Conc (mg/ml) 
%Recovery 
 
50% 
50.50 0.50500 0.51221 101.43 
50.80 0.50800 0.51354 101.09 
50.70 0.50700 0.51431 101.44 
 
100% 
99.30 0.99300 0.98134 98.83 
99.50 0.99500 0.97858 98.35 
99.50 0.99500 0.98305 98.80 
150% 
150.70 1.50700 1.53332 101.75 
151.40 1.51400 1.53993 101.71 
151.80 1.51800 1.53902 101.38 
 
          The percentage recovery values were in the range of 98.35%- 101.75% 
which is within the acceptance criteria 
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Table 7.7: Accuracy of biotin 
Level 
% BI Working 
strength 
Theoretical 
Conc (mg/ml) 
Measured 
Conc (mg/ml) 
% Recovery 
 
50% 
49.00 0.04900 0.04941 100.84 
50.00 0.05000 0.05009 100.18 
49.00 0.04900 0.04948 100.98 
 
100% 
101.00 0.10100 0.10171 100.70 
102.00 0.10200 0.10201 100.01 
103.00 0.10300 0.10257 99.58 
150% 
151.00 0.15100 0.14963 99.09 
150.00 0.15000 0.14788 98.59 
149.00 0.14900 0.14817 99.44 
                   
           The percentage recovery values were in the range of 98.59%- 
100.98% which is within the acceptance criteria. 
5. Method precision: 
          The method precision was performed by analyzing a sample solution of 
Hairgro tablets (B.No: RD16047) as per the test method (six replicate sample 
preparation). A typical chromatogram for method precision is shown in     
Figure – 7.18 
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Figure7.18: Chromatogram of method precision 
Table 7.8: Summary of results for precision of the method 
Sample    Level % Assay (CP) % Assay(BI) 
1 100% 104.39 106.83 
2 100% 102.99 103.84 
3 100% 104.47 106.43 
4 100% 105.31 106.55 
5 100% 102.53 102.90 
6 100% 102.54 104.42 
Average 103.71 105.16 
%RSD 1.13 1.58 
 
          The %RSD for the assay values of calcium pantothenate and biotin in 
Hairgro tablets were 1.13 % and 1.58 % respectively. 
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6. Ruggedness (Intermediate Precision) 
 The ruggedness of the method was performed by analyzing a sample 
solution of Hairgro tablets (B.No: RD16047) as per the test method (six 
replicate sample preparation) and injected each solution in duplicate using 
different instrument, column, reagent, and analyst on different days. The 
results of set I were compared with the results of set II. A typical 
chromatogram for ruggedness is shown in Figure-7.19. Table 7.10 
summerizes the results for ruggedness 
Table 7.9 
Parameter Set I Set II 
Instrument to instrument Instrument – 1 Instrument – 2 
Column to column Column – 1 Column – 2 
Reagent to reagent Reagent – 1 Reagent – 2 
Analyst to analyst Analyst – 1 Analyst – 2 
Day to day Day – 1 Day – 2 
 
 
Figure 7.19: Chromatogram of ruggedness 
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Table 7.10: Summary of results for ruggedness 
Sample 
Set – I Set – II Set – I Set – II 
CP CP BI BI 
1 104.39 106.83 103.68 103.90 
2 102.99 103.84 103.16 103.00 
3 104.47 106.43 103.82 103.80 
4 105.31 106.55 103.82 103.90 
5 102.53 102.90 105.09 105.10 
6 102.54 104.42 104.52 104.40 
Average 103.71 105.16 104.02 104.02 
% RSD 1.13 1.58 0.66 0.67 
Overall 
Avg 
103.84 104.59 
Overall             
% RSD 
0.89 1.29 
Set Set - I Set – II 
Instrument I/RD/HPC/02 I/RD/HPC/04 
Column 
Cosmosil ,5C18-MS-II 
(250 X 4.6 mm, 5µ), 
RD/COL/76 
Cosmosil ,5C18-MS-II 
(250 X 4.6 mm, 5µ), 
RD/COL/77 
Reagent 
KH2PO4 (Rankem) 
Methanol (Fisher) 
KH2PO4 (Finar) 
Methanol (Finar) 
Analyst Analyst-1 Analyst-2 
        
    The above result indicates that the test method is rugged for instrument 
to instrument, column to column, reagent to reagent, analyst to analyst and 
day to day variation. The overall % RSD for the assay value of calcium 
pantothenate and biotin in Hairgro tablets was 0.89% and 1.29% respectively. 
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7. Robustness: 
           The following table (Table 7.11) shows the parameters of the method 
that were altered to test the robustness of the method. The robustness of the 
method is to be determined by analyzing the standard solution six times with 
varying RP-HPLC conditions as described below. A typical chromatogram for 
robustness is shown in Figure-7.20 – 7.37  
Table 7.11:   Parameters altered for robustness test 
Parameter Actual Low High 
Flow rate 1.00 ml/min 0.90 ml/min 1.10 ml/min 
Mobile phase ratio 70 :  30 72 :  28 68 :  32 
Buffer pH 2.20 2.10 2.30 
Column oven temperature 30°C 28°C 32°C 
  
7.1 Chromatographic conditions (Actual):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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Figure 7.20: Chromatogram of robustness- standard (Actual) 
 
Figure 7.21: Chromatogram of robustness- sample (Actual) 
7.2 Chromatographic conditions (Flow-Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 0.9 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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Figure 7.22: Chromatogram of robustness- standard (Flow low) 
 
Figure 7.23: Chromatogram of robustness- sample (Flow low) 
7.3 Chromatographic conditions (Flow-High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.1 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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Figure 7.24: Chromatogram of robustness- standard (Flow high) 
 
 
Figure 7.25: Chromatogram of robustness- sample (Flow high) 
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Table 7.12: Summary of robustness results of standard (Flow) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.30-4.53 
9.09- 
9.27 
4.22-4.23 
8.12- 
8.16 
4.57- 
4.59 
10.16- 
10.43 
Area 
4966028- 
4991449 
745914- 
779360 
4836134- 
4872558 
764132- 
771434 
4940974- 
5020412 
782565- 
791915 
Tailing 
factor 
1.19 1.05 1.21 1.03 1.21 1.01 
Theoretical 
plates 
8586 14487 8604 13715 8586 14487 
Average 
(Area) 
4978738 762637 4850959 772652 4967201 786025 
%RSD 
(Area) 
0.27 0.65 0.28 0.73 0.59 0.43 
 
Table 7.13: Summary of robustness results of sample (Flow) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.31-4.40 
9.09- 
9.27 
5.14-5.22 
11.29- 
11.38 
4.13-4.15 
8.99- 
9.05 
Area 
5003737- 
4966028 
735393- 
745914 
5775729-
5640003 
873982- 
890362 
4585191- 
4469026 
715423- 
720801 
Tailing 
factor 
1.23 1.05 1.19 1.02 1.20 1.03 
Theoretical 
plates 
8638 14392 10171 16407 8501 14020 
Average 
(Area) 
4985023 740081 
5705806 
 
885693 
4519688 
 
718206 
%RSD 
(Area) 
0.24 0.60 0.98 0.73 1.14 0.38 
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7.4 Chromatographic conditions (Mobile Phase – Ratio - Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (72: 28) 
 
 
Figure 7.26: Chromatogram of robustness- standard ( MP ratio low) 
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Figure 7.27: Chromatogram of robustness- sample (MP ratio low) 
7.5 Chromatographic conditions (Mobile Phase – Ratio - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (68: 32) 
 
Figure 7.28: Chromatogram of robustness- standard (MP ratio high) 
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Figure 7.29: Chromatogram of robustness- sample (MP ratio high) 
Table 7.14: Summary of robustness results of standard (Mobile phase ratio) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.30-4.53 
9.09- 
9.27 
4.83- 
4.95 
12.07- 
12.28 
4.73-4.74 
11.08- 
11.10 
Area 
4966028- 
4991449 
745914- 
779360 
5025626- 
5106931 
791713- 
798454 
4995979- 
5003793 
785982- 
801047 
Tailing 
factor 
1.19 1.05 1.20 1.01 1.20 1.03 
Theoretical 
plates 
8586 14487 9139 14853 9434 15471 
Average 
(Area) 
4978738 762637 5060695 796461 4999953 792574 
%RSD 
(Area) 
0.27 0.65 0.71 0.32 0.06 0.67 
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Table 7.15: Summary of robustness results of sample (Mobile phase ratio) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.31-4.40 
9.09- 
9.27 
4.73-4.74 
11.08- 
11.10 
4.22-4.23 
8.12- 
8.16 
Area 
5003737- 
4966028 
735393- 
745914 
4995979- 
5003793 
785982- 
801047 
4836134- 
4872558 
764132- 
771434 
Tailing 
factor 
1.23 1.05 1.20 1.03 1.21 1.03 
Theoretical 
plates 
8638 14392 9434 15471 8604 13715 
Average 
(Area) 
4985023 740081 4999953 792574 4850959 772652 
%RSD 
(Area) 
0.24 0.60 0.06 0.67 0.28 0.73 
  
7.6 Chromatographic conditions (Buffer pH - Low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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Figure 7.30: Chromatogram of robustness- standard (Buffer pH low) 
 
Figure 7.31: Chromatogram of robustness- sample (Buffer pH low)  
7.7 Chromatographic conditions (Buffer pH - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven Temperature  : 30°C 
Mobile phase  : Buffer: methanol (70: 30) 
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Figure 7.32: Chromatogram of robustness- standard (Buffer pH high) 
 
 
Figure 7.33: Chromatogram of robustness- sample (Buffer pH high) 
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Table 7.16: Summary of robustness results of standard (Buffer pH) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.30-4.53 
9.09- 
9.27 
4.48- 
4.52 
9.53- 
9.73 
5.14-5.22 
11.29- 
11.38 
Area 
4966028- 
4991449 
745914- 
779360 
4911396- 
5003080 
784140- 
793037 
5775729-
5640003 
873982- 
890362 
Tailing 
factor 
1.19 1.05 1.21 1.03 1.19 1.02 
Theoretical 
plates 
8586 14487 8634 14573 10171 16407 
Average 
(Area) 
4978738 762637 4937913 789483 
5705806 
 
885693 
%RSD 
(Area) 
0.27 0.65 0.68 0.63 0.98 0.73 
 
Table 7.17: Summary of robustness results of sample (Buffer pH) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.31-4.40 
9.09- 
9.27 
4.61-4.63 
10.48-
10.68 
4.83- 
4.95 
12.07- 
12.28 
Area 
5003737- 
4966028 
735393- 
745914 
4949496- 
4988077 
790990- 
797800 
5025626- 
5106931 
791713- 
798454 
Tailing 
factor 
1.23 1.05 1.20 1.00 1.20 1.01 
Theoretical 
plates 
8638 14392 9123 14763 9139 14853 
Average 
(Area) 
4985023 740081 4971249 793773 5060695 796461 
%RSD 
(Area) 
0.24 0.60 0.34 0.38 0.71 0.32 
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7.8 Chromatographic conditions (Column oven temperature - low):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven Temperature  : 28°C 
Mobile phase  : Buffer: methanol (70: 30) 
 
Figure 7.34: Chromatogram of robustness- standard (column temp low) 
 
Figure 7.35: Chromatogram of robustness- sample (column temp low) 
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7.9 Chromatographic conditions (Column oven temperature - High):  
Column   : Cosmosil, C18, 250 X 4.6 mm, 5 μm or equivalent 
Flow rate   : 1.0 ml / min 
Detection wavelength : 210 nm 
Injection volume  : 20 L 
Oven temperature  : 32°C 
Mobile phase  : Buffer: methanol (70: 30) 
 
Figure 7.36: Chromatogram of robustness- standard (column temp high) 
 
Figure 7.37: Chromatogram of robustness- sample (column temp high) 
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Table 7.19: Summary of robustness results of standard (Column 
temperature) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.30-4.53 
9.09- 
9.27 
4.13-4.15 
8.99- 
9.05 
4.61-4.63 
10.48-
10.68 
Area 
4966028- 
4991449 
745914- 
779360 
4585191- 
4469026 
715423- 
720801 
4949496- 
4988077 
790990- 
797800 
Tailing 
factor 
1.19 1.05 1.20 1.03 1.20 1.00 
Theoretical 
plates 
8586 14487 8501 14020 9123 14763 
Average 
(Area) 
4978738 762637 
4519688 
 
718206 4971249 793773 
%RSD 
(Area) 
0.27 0.65 1.14 0.38 0.34 0.38 
 
Table 7.20: Summary of robustness results of sample (Column 
temperature) 
Flow 
Actual Low High 
CP BI CP BI CP BI 
RT (min) 4.31-4.40 
9.09- 
9.27 
4.57- 
4.59 
10.16- 
10.43 
4.48- 
4.52 
9.53- 
9.73 
Area 
5003737- 
4966028 
735393- 
745914 
4940974- 
5020412 
782565- 
791915 
4911396- 
5003080 
784140- 
793037 
Tailing 
factor 
1.23 1.05 1.21 1.01 1.21 1.03 
Theoretical 
plates 
8638 14392 8586 14487 8634 14573 
Average 
(Area) 
4985023 740081 4967201 786025 4937913 789483 
%RSD 
(Area) 
0.24 0.60 0.59 0.43 0.68 0.63 
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8. Solution stability 
     Measure the stability of the Hairgro tablets test solution against 100% of 
the standard concentration by keeping the solution up to 48 hours at 15C. 
Inject the sample at different time intervals (i.e: Initial, 6, 12, 18, 24, 36& 48 
hours) as per the method. A typical chromatogram for solution stability is 
shown in Figure- 7.38- 7.45 
 
Figure 7.38: Chromatogram of solution stability- Initial 
 
Figure 7.39: Chromatogram of solution stability- 6 hours 
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Figure 7.40: Chromatogram of solution stability- 12 hours 
 
Figure 7.41: Chromatogram of solution stability- 18 hours 
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Figure 7.42: Chromatogram of solution stability- 24 hours 
 
Figure 7.43: Chromatogram of solution stability- 36 hours 
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Figure 7.44: Chromatogram of solution stability- 48 hours 
Table 7.21: Summary of solution stability results 
Time intervals % CP % BI 
Initial 103.64 104.61 
6 hours 103.39 104.30 
12 hours 103.81 105.01 
18 hours 104.08 105.42 
24 hours 103.67 104.58 
36 hours 104.05 105.26 
48 hours 103.69 104.55 
% RSD 0.23 0.40 
 
 The assay values of calcium pantothenate in Hairgro tablets were in 
the range of 103.39% to 104.08%. The %RSD between the assay results 
from the initial to 48 hours was 0.23, which is within the acceptance limit of 
2.0%. The assay values of biotin in Hairgro tablets was in the range of 
104.30% to 105.42%. The %RSD between the assay results from the initial to 
48 hours was 0.40, which is within the acceptance limit of 2.0%. Therefore, 
the Hairgro tablets sample solutions are stable up to 48 hours at 15°C. 
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DISCUSSION 
The working condition for the RP-HPLC method were established for 
biotin and calcium pantothenate then applied on pharmaceutical dosage form. 
Mobile phase system were prepared and used to provide ratio of 
Buffer: methanol (70:30) gave a better resolution and sensitivity. The retention 
time of biotin and calcium pantothenate were found to be 9.79 and 4.53 
respectively. The asymmetry factor or tailing factor of biotin and calcium 
pantothenate is 1.05 and 1.23 respectively which indicates symmetrical nature 
of peak. 
The number of theoretical plates of biotin and calcium pantothenate 
was 14392 and 8638 respectively which indicates efficient performance of 
column. The retention time of drugs were found to be within the limits of 0-10 
minutes. These parameters represent the specificity of method. 
From the linearity studies, specified concentration range was 
determined. It was observed that biotin and calcium pantothenate were in the 
range of 50% - 150% each for the target concentration. The linearity range is 
0.5 – 1.5mg/ml for calcium pantothenate and 0.05 – 0.15mg/ml for biotin 
were found to obey linearity with correlation coefficient of 0.9976 for calcium 
pantothenate and 0.9997 for biotin. The validation for the proposed method 
was verified by system precision and method precision. There was %RSD of 
system precision for biotin and calcium pantothenate was 0.60 and 0.24 
respectively. The method precision was conducted and the % label claim was 
obtained as 103.71% for calcium pantothenate and 105.16% for biotin. The % 
recovery value of 98.35% - 101.75% for calcium pantothenate and 98.58% - 
100.98% for biotin indicates non-interferences of excipient in the formulation. 
The validation of the proposed method was verified by recovery 
studies. The robustness studies were performed by changing the flow-rate, 
pH, column temperature and mobile phase concentration. The ruggedness 
studies were performed. All parameters including flow-rate, temperature, 
detector, wavelength and sensitivity were maintained constant throughout the 
procedure. The analytical method validation was carried as per the ICH 
guidelines.
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SUMMARY REPORT: 
S.No Parameters Observation Acceptance Criteria 
1 
Specificity 
Placebo 
Interference 
No peak was 
observed at the 
retention time of   
calcium 
pantothenate and 
biotin in the 
chromatogram of 
placebo 
The placebo 
chromatogram should not 
show any peak at the 
retention time of calcium 
pantothenate and biotin. 
2 
System precision 
(a) Calcium 
pantothenate 
1.23 Tailing factor: NMT 2.0 
8638 
Theoretical plates :NLT 
2000 
0.24 % RSD: NMT 2.0 
(b) Biotin 
1.05 Tailing factor :NMT 2.0 
14392 
Theoretical plates: NLT 
2000 
0.60 % RSD: NMT 2.0 
3 
Linearity & Range 
(a) Calcium 
pantothenate 
 
0.9976 
 
Correlation coefficient: 
NLT 0.995 
(b) Biotin 0.9997 
4 
Accuracy 
(a) Calcium 
pantothenate 
98.35 – 101.75 % 98.0 – 102.0% 
 
(b) biotin 98.58 – 100.98 % 
5 
Method Precision           
(a) Calcium 
pantothenate 
1.13 
% RSD : NMT 2.0 (Assay) 
(b) Biotin 1.58 
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S. 
No 
Parameters Observation Acceptance criteria 
6 
 
 
Ruggedness                   
(a) Calcium 
pantothenate 
0.89 
Overall % RSD NMT 2.0 
(assay) 
 
(b) Biotin 1.29 
7 
 
 
 
 
 
Robustness                       
(a) Calcium 
pantothenate 
1.19 – 1.23 
 
Tailing factor: NMT 2.0 
8501 – 10171 
Theoretical plates: NLT 
2000 
0.06 – 1.14 % RSD: NMT 2.0 
(b) Biotin 
1.00 – 1.05 Tailing factor: NMT 2.0 
13715 – 
16403 
Theoretical plates: NLT 
2000 
0.32 – 0.73 % RSD: NMT 2.0 
8 
 
 
Solution stability          
(a) Calcium 
pantothenate 
0.23 
 
%RSD NMT : 2.0  (assay) 
 
(b) Biotin 0.40 
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CONCLUSION 
Cosmosil C18 column as stationary phase and phosphate buffer: 
methanol (70: 30) as a mobile phase and 210 nm is selected for the detection 
in this RP-HPLC. 
The system precision shows RSD value obtained was below 1 which 
indicate precision and system suitability indicates retention time for calcium 
pantothenate and biotin were 4.53 and 9.79 respectively. 
Co-effecient of correlation for calcium pantothenate and biotin denote 
sensitivity. 
Quantitative estimation of calcium pantothenate and biotin gives 
accuracy which lies between 98.35% – 101.75% for calcium pantothenate and 
98.58% - 100.98% for biotin. 
By using system to system suitability and analyst to analyst variability 
all the parameters met the system suitability. 
The percentage purity of calcium pantothenate and biotin lies in 
between 103.71% and 105.16% respectively. 
The proposed RP-HPLC method was simple, precise, rapid & accurate 
and involves easy sample preparation. The linearity, reproducibility and 
recovery data confirms no major interferences in the assay determination. So, 
this method can be used for routine quality control analysis of this drug. 
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GLOSSARY 
% -  Percentage 
µg - Microgram 
ng - Nanogram 
AR - Analytical Reagent 
M - Molarity 
N - Normality 
mg - Milli gram 
mins - Minutes 
ml - Milli liter 
mm - Milli meter 
NA - Not Applicable 
RP-HPLC - Reverse Phase- High Performance Liquid chromatography 
ICH - International Conference on Harmonization 
BI - Biotin 
CP - Calcium Pantothenate 
KH2PO4 - Potassium dihydrogen orthophosphate 
H3PO4 - Phosphoric acid 
NMT - Not more than 
NLT - Not less than 
pH - Negative logarithm of hydrogen ion concentration 
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